Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

Fla. Death Damages Row Signals Insurers' Tort Reform Focus No Photo Available

Abraham Gross

Florida Gov. Ron DeSantis' veto of a bill that would have repealed limits on noneconomic damages in fatal medical malpractice cases — ... (more story)

Stewart's Newest Discretionary Denial Has Attys On Edge No Photo Available

Dani Kass

The acting U.S. Patent and Trademark Office director's decision on Friday to reject patent challenges due to the petitioner's long-sta... (more story)

Healthcare Deals This Week: Omada, Antares, Amplify No Photo Available

Yeji Jesse Lee

The healthcare industry saw a few notable deals this past week, including a much-anticipated IPO from digital health company Omada and... (more story)